Merck KGaA

General ticker "MKGAF" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - Specialty & Generic
  • Capitalization: $59.5B (TTM average)

Merck KGaA follows the US Stock Market performance with the rate: 15.7%.

Estimated limits based on current volatility of 3.0%: low 147.98$, high 157.07$

Factors to consider:

  • Company pays dividends (annually): last record date 2025-04-29, amount 2.50$ (Y1.65%)
  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [111.55$, 176.63$]
  • 2025-12-31 to 2026-12-31 estimated range: [113.61$, 178.47$]

Financial Metrics affecting the MKGAF estimates:

  • Negative: with PPE of 19.6 at the end of fiscal year the price was high
  • Positive: 7.61 < Operating profit margin, % of 17.23
  • Positive: 42.77 < Shareholder equity ratio, % of 58.01 <= 64.37
  • Positive: 6.66 < Operating cash flow per share per price, % of 7.58
  • Positive: 1.84 < Return on assets ratio (scaled to [-100,100]) of 5.11
  • Positive: Inventory ratio change, % of 0.20 <= 0.79
  • Negative: Industry earnings per price (median), % of 0 <= 0
  • Negative: negative Industry operating cash flow (median)
  • Positive: Interest expense per share per price, % of 0.48 <= 0.73

Similar symbols

Short-term MKGAF quotes

Long-term MKGAF plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue €22,232.00MM €20,993.00MM €21,156.00MM
Operating Expenses €17,758.00MM €17,384.00MM €17,511.00MM
Operating Income €4,474.00MM €3,609.00MM €3,645.00MM
Non-Operating Income €-187.00MM €-125.00MM €-109.00MM
Interest Expense €207.63MM €272.00MM €292.00MM
R&D Expense €2,521.00MM €2,445.00MM €2,279.00MM
Income(Loss) €4,287.00MM €3,484.00MM €3,536.00MM
Taxes €948.00MM €650.00MM €751.00MM
Profit(Loss)* €3,326.00MM €2,824.00MM €2,777.00MM
Stockholders Equity €25,927.00MM €26,680.00MM €29,912.00MM
Inventory €4,632.00MM €4,637.00MM €4,484.00MM
Assets €48,526.00MM €48,495.00MM €51,567.00MM
Operating Cash Flow €4,259.00MM €3,784.00MM €4,586.00MM
Capital expenditure €1,806.00MM €2,023.00MM €2,184.00MM
Investing Cash Flow €-2,743.00MM €-1,892.00MM €-3,050.00MM
Financing Cash Flow €-1,555.00MM €-1,732.00MM €-985.00MM
Earnings Per Share** €7.65 €6.49 €6.39

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.